artificial intelligence
Can this AI platform change the future of cancer treatments?
Panna Sharma, CEO of clinical stage oncology biotech Lantern Pharma, speaks to EPM about how his company’s artificial intelligence platform could help revolutionise drug development and ultimately change the way we treat cancer. Read more
CPhI 2019 Annual Report: new technologies vital to future of pharma manufacturing
New technologies such as artificial intelligence (AI) could revolutionise pharmaceutical manufacturing but only if regulators change to prevent hindering future innovation. Read more
Download! EPM's September 2018 issue is available
The September issue of @EPM_magazine is available for download with all the regulars and features on artificial intelligence, formulation, analytical lab techniques, artificial intelligence, APIs/HPAPIs plus a serialisation supplement. Read more
Strategic partnership sees creation of ‘foolproof’ blockchain solutions
Systech — a global company specialising in brand protection and product authentication — and FarmaTrust — pharmaceutical supply chain company — have formed a strategic partnership for a ‘foolproof’ pharma blockchain solution. Read more
The AI will see you now — how big data and advanced analytics are changing the game in epilepsy
In this online exclusive, Erik Janssen, vice president of Global New Patient Solutions Neurology at UCB, talks about why advancements in big data and analytics might be the key to helping patients with epilepsy. Read more
Some hurdles left to overcome in use of big data
Big data has the potential to provide scientists with important insights but there are still some barriers to its widespread use that need to be overcome. In this article, Paul Denny-Gouldson from IDBS tells us more… Read more
Pfizer Healthcare Hub: London: The start-up tackling data and AI in healthcare
In the last of a series of articles surrounding the Pfizer Healthcare Hub: London, founder and CEO of Illumr, Jason Lee, talks to reporter Reece Armstrong about the use of AI and data within healthcare. Read more
Survey reveals that 72% of life science professionals believe industry is lagging in AI development
A survey from The Pistoia Alliance has revealed that nearly three-quarters (72%) of life science professionals believe their industry is behind the curve in the development of artificial intelligence (AI). Read more
Funding for ambitious technology projects announced that will transform drug discovery
Funding for a series of ambitious technology projects set to transform drug discovery has been announced by business secretary, Greg Clark. Read more
Do androids dream of electric drugs? Looking at the AI space in pharma
As the race to dominate the artificial intelligence (AI) space steps up a gear, I take a look at how AI finds use in pharma and how different regions plan to invest in this exciting area. Read more
Nearly two-thirds of drug safety experts plan to use AI for safety, says research
New research from Oracle Health Services in partnership with Informa Engage/Pharma Intelligence has revealed that more than 60% of drug safety experts are planning to use artificial intelligence (AI) to improve the speed and security Read more
Life sciences industry should collaborate more to build the LoTF, says the Pistoia Alliance
The Pistoia Alliance, a not for profit alliance, has called on the life sciences industry to support the ‘Lab of the Future’ (LoTF) through greater collaboration during its annual EU member conference held in London. Read more
Innovate UK awards grant for development of AI supported warning system for patients with respiratory disease
Innovate UK, the country’s innovation agency, has awarded a grant to Aseptika and Zenzium for the development of a new home-based early warning system, using artificial intelligence (AI), for people with severe respiratory disease. Read more
Winners of President’s Startup Challenge announced
The winners of the 2017 Pistoia Alliance President’s Startup Challenge have been announced as Medley Genomics (grand prize winner) and Transformative AI (audience vote winner). Read more
Exscientia and GSK announce strategic collaboration
Exscientia and GlaxoSmithKline (GSK) have entered into a strategic collaboration to apply an AI-enabled platform in the discovery of novel and selective small molecules for up to 10 disease-related targets. Read more
Big data and asthma intelligence set to benefit pharmaceutical companies
Pharmaceutical companies set to benefit from intelligence on asthma as Aerobit teams with artificial intelligence experts to unlock the potential of big data. Read more
